Improvement in sexual functioning and satisfaction in nonresponders to testosterone gel: clinical effectiveness in hypogonadal, HIV-positive males (Q39351891)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 2005

Language	Label	Description	Also known as
English	Improvement in sexual functioning and satisfaction in nonresponders to testosterone gel: clinical effectiveness in hypogonadal, HIV-positive males	scientific article published on January 2005

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Improvement in sexual functioning and satisfaction in nonresponders to testosterone gel: clinical effectiveness in hypogonadal, HIV-positive males (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Shannon Schrader

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Anthony Mills

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Mark Scheperle

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Jon E Block

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

publication date

1 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Clinical cornerstone

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

7 Suppl 4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

S26-31

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Endocrine disorders in men infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980095-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum hormones in men with human immunodeficiency virus-associated wasting

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980095-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in the hypothalamic-pituitary-gonadal axis in human immunodeficiency virus-infected homosexual men.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980095-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence of endocrine involvement early in the course of human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980095-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Sexual dysfunction in advanced HIV disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980095-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Testosterone Replacement Treatment Options for HIV-Infected Men

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980095-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Androgen therapy in AIDS wasting

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980095-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Testosterone treatment of clinical hypogonadism in patients with HIV/AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980095-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Testosterone replacement therapy in HIV illness

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980095-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980095-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Testosterone therapy for human immunodeficiency virus-positive men with and without hypogonadism

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980095-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980095-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980095-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Restorative increases in serum testosterone levels are significantly correlated to improvements in sexual functioning

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980095-X

7 January 2021

based on heuristic

inferred from DOI database lookup

AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980095-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A brief male sexual function inventory for urology

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980095-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Masculine vitality: pros and cons of testosterone in treating the andropause

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980095-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Androgen deficiency in the aging male: when, who, and how to investigate and treat

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980095-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the pharmacokinetic profiles of the new testosterone topical gel formulation, Testim, compared to AndroGel

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980095-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980095-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1098-3597(05)80095-X

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39351891&oldid=1822236120"